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Background: Tissue engineering represents an enormous advantage for the treatment of Tetralogy of Fallot.
Methods: In this study we compared the use of endothelial cells (EC) and smooth muscle cells (SMC) derived from the carotid artery (group 1/ 
n=5) with CD133+-cells derived from bone-marrow (group 2/ n=5). Western blot analysis and histology were done before and after percutaneous 
implantation of the pulmonary valved stent. After seeding of the pulmonary valved stent with one of the cell groups, the construct was placed 
in a dynamic bioreactor for 16 days. The calcification can be classified in grade 0 (no calcification), grade 1 (micro-), grade 2 (mild-), grade 3 
(moderate-) and grade 4 (strong calcification).
Results: Western blot analysis demonstrated a mixture of SMCs and ECs in group 1, while in group 2 only CD133+-cells were detected. Three 
months after implantation, CD31-staining demonstrated a typical cobblestone-like morphology in both groups. Immuno[[Unsupported Character 
- Codename &shy;]]histochemistry revealed strong expression of _-smooth muscle actin and in-growth into the leaflets in the two groups. CD3-, 
CD20-, CD45- and CD68-staining confirmed no signs of inflammation in all analyzed animals in group 2, in group 1 small amounts of inflammation 
were detected. Von Kossa staining revealed only mild to moderate calcification in the annular region of group 1. In contrast, no calcification was 
detected in group 2.
Conclusions: This study demonstrates that autologous CD133+-cells derived from bone-marrow had a better outcome with regard to calcification 
and inflammation compared to the cells derived from carotid artery.
